中轴型银屑病关节炎与伴或不伴银屑病的强直性脊柱炎是否不同?
本研究比较了来自强直性脊柱炎(AS)门诊的伴银屑病AS(ASP)和不伴银屑病AS(AS)患者与来自银屑病关节炎(PsA)门诊的中轴型PsA(axPsA)和外周型PsA患者。结果显示AS患者(无论是否伴银屑病)在人口学、遗传学、临床和影像学上与axPsA患者不同,axPsA似乎是一个独立疾病实体。
要点
- AS患者较axPsA更年轻、男性更多、HLA-B*27阳性率更高。
- AS患者就诊时背痛更常见、中轴疾病活动度和活动度评分更差。
- AS患者生物制剂使用更多、骶髂关节炎分级更高。
核心结论
- 伴或不伴银屑病的AS患者在人口学、遗传学、临床和影像学上与axPsA患者不同,axPsA似乎是独立疾病实体。
研究设计与样本
- 从AS门诊招募成人ASP和AS队列,从PsA门诊招募成人axPsA(影像学骶髂关节炎:双侧≥2级或单侧3或4级)和外周型PsA队列,前瞻性按同一方案随访。
主要发现
- AS患者更年轻(P < 0.001),男性更多,HLA-B*27阳性率更高(AS 76%、ASP 72% vs axPsA 64%,P ≤ 0.001;AS 82%、ASP 75% vs axPsA 19%,P = 0.001)。
- AS患者就诊时背痛更常见(AS 90%、ASP 92% vs axPsA 19%,P = 0.001),BASDAI更高(4.1、3.9 vs 3.5,P = 0.017),BASMI更差(2.9、2.2 vs 1.8,P < 0.001)。
- AS患者医生总体评估更差(2.4、2.2 vs 2.1,P < 0.001),生物制剂使用更多(29%、21% vs 7%,P = 0.001),骶髂关节炎分级更高(90%、84% vs 51%,P < 0.001)。
- ASP与axPsA的比较及回归模型中也检测到类似差异。
临床怎么用
- 临床上应将axPsA视为与AS不同的独立疾病实体进行鉴别诊断和评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to compare patients with ankylosing spondylitis with psoriasis (ASP) and without psoriasis (AS), to axial PsA (axPsA) patients. METHODS: Two adult cohorts were recruited from the AS clinic: ASP and AS. These two cohorts were compared with two adult cohorts recruited from the PsA clinic: axPsA (radiographic sacroiliitis: ⩾bilateral grade 2 or unilateral grade 3 or 4); and Peripheral PsA. All patients were followed prospectively according to the same protocol. The demographic, clinical and radiographic variables were compared. Adjusted means were used to account for varying intervals between visits. A logistic regression was performed and adjusted for follow-up duration. RESULTS: There were 477 axPsA patients, 826 peripheral PsA, 675 AS and 91 ASP patients included. AS patients were younger (P < 0.001), more male and HLA-B*27 positive (76%, 72% vs 64%, P ⩽ 0.001, 82%, 75%, vs 19%, P = 0.001). They had more back pain at presentation (90%, 92% vs 19%, P = 0.001), worse axial disease activity scores (bath ankylosing spondylitis disease activity index: 4.1, 3.9 vs 3.5 P = 0.017), worse back metrology (bath ankylosing spondylitis metrology index: 2.9, 2.2 vs 1.8, P < 0.001), worse physician global assessments (2.4, 2.2 vs 2.1, P < 0.001), were treated more with biologics (29%, 21% vs 7%, P = 0.001) and had a higher grade of sacroiliitis (90%, 84% vs 51%, P < 0.001). Similar differences were detected in the comparison of ASP to axPsA and in a regression model. CONCLUSION: AS patients, with or without psoriasis, seem to be different demographically, genetically, clinically and radiographically from axPsA patients. axPsA seems to be a distinct entity.
引用
- Feld J, Ye JY, Chandran V, et al. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? Rheumatology (Oxford). 2020. PMID: 31593590. doi:10.1093/rheumatology/kez457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。